Publications by authors named "Helka Parviainen"

Claim this Profile
P
Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation.
Susanna Majala, Lauri Elonen, Tuomas Kaprio, Tiina Vesterinen, Saila Kauhanen, Helka Parviainen

Br J Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromogranin a and pancreatic polypeptide are not suitable for the screening of pancreatic neuroendocrine tumors in MEN1 - a long-term follow-up study.
Iiro Kostiainen, Susanna Majala, Jukka Schildt, Helka Parviainen, Saila Kauhanen

Endocrine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and external validation of prediction risk scores (STRISK and NOFA) to predict immediate surgical need in adhesive small bowel obstruction: an observational prospective multicentre study.
Panu Räty, Akseli Bonsdorff, Helka Parviainen, Eila Lantto, Thomas Hackenberg

Br J Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: the utility of gallium-68 PET/CT in MEN1 related parathyroid disease.
Iiro Kostiainen, Jukka Schildt, Helka Parviainen, Eeva M Ryhänen, Camilla Schalin-Jäntti

Eur J Endocrinol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hidden epidemic: Uncovering incidental fatty liver disease and its metabolic comorbidities by datamining in a hospital data lake - A real-world cohort study.
Iiro P Karhiaho, Samu H Kurki, Helka I Parviainen, Liisa Kullamaa, Martti A Färkkilä

Diabetes Res Clin Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
Marja-Riitta Taskinen, Niina Matikainen, Elias Björnson, Sanni Söderlund, Jussi Inkeri, Helka Parviainen

Diabetologia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
Iiro Kostiainen, Susanna Majala, Jukka Schildt, Helka Parviainen, Saila Kauhanen

Eur J Endocrinol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter- and Intra-Observer Variability and the Effect of Experience in Cine-MRI for Adhesion Detection.
Bram de Wilde, Frank Joosten, Wulphert Venderink, Mirjam E J Davidse, Juliëtte Geurts, Helka Parviainen

J Imaging· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Morbidity of Choledochal Malformations in Children.
Ilona Hyvärinen, Maria Hukkinen, Reetta Kivisaari, Helka Parviainen, Heikki Mäkisalo

J Pediatr Gastroenterol Nutr· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenocortical carcinoma: presentation and outcome of a contemporary patient series.
Iiro Kostiainen, Liisa Hakaste, Pekka Kejo, Helka Parviainen, Tiina Laine

Endocrine· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer.
Anna Nurmi, Harri Mustonen, Helka Parviainen, Katriina Peltola, Caj Haglund

Acta Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biliary Anomalies in Patients With HNF1B Diabetes.
Jarno L T Kettunen, Helka Parviainen, Päivi J Miettinen, Martti Färkkilä, Marjo Tamminen

J Clin Endocrinol Metab· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.
Helka Parviainen, Anja Schrade, Sanne Kiiveri, Renata Prunskaite-Hyyryläinen, Caj Haglund

Pathol Res Pract· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA4 is a critical regulator of gonadectomy-induced adrenocortical tumorigenesis in mice.
Justyna Krachulec, Melanie Vetter, Anja Schrade, Ann-Kathrin Löbs, Malgorzata Bielinska, Helka Parviainen

Endocrinology· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WNT4 is expressed in human fetal and adult ovaries and its signaling contributes to ovarian cell survival.
Minna Jääskeläinen, Renata Prunskaite-Hyyryläinen, Florence Naillat, Helka Parviainen, Mikko Anttonen

Mol Cell Endocrinol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA transcription factors in adrenal development and tumors.
Helka Parviainen, Sanne Kiiveri, Malgorzata Bielinska, Nafis Rahman, Ilpo T Huhtaniemi

Mol Cell Endocrinol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA-4:FOG interactions regulate gastric epithelial development in the mouse.
Christina M Jacobsen, Susanna Mannisto, Susan Porter-Tinge, Elena Genova, Helka Parviainen

Dev Dyn· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice.
Malgorzata Bielinska, Elena Genova, Irving Boime, Helka Parviainen, Sanne Kiiveri

Endocrinology· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor.
Malgorzata Bielinska, Helka Parviainen, Susan B Porter-Tinge, Sanne Kiiveri, Elena Genova

Endocrinology· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOG-2 and GATA-4 Are coexpressed in the mouse ovary and can modulate mullerian-inhibiting substance expression.
Mikko Anttonen, Ilkka Ketola, Helka Parviainen, Anna-Kaisa Pusa, Markku Heikinheimo

Biol Reprod· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis